Showing results (91-100 of 151) with videos related to
Sort By:
Pageof 16
The New England Journal of Medicine|January 10, 1991
Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitusK Zeller, E Whittaker, L Sullivan, et al.Diabetes|July 1, 1980
Effect of streptozotocin-induced diabetes on renal ornithine decarboxylase activityJ H Levine, M G Buse, A B Leaming, et al.Clinical Therapeutics|September 1, 1991
Transfer of patients with diabetes from semisynthetic human insulin to human insulin prepared by recombinant DNA technology using baker's yeast: a double-blind, randomized studyJ A Davidson, L C Ramirez, P Raskin, et al.Endocrinology|October 1, 1978
Effect of streptozotocin-induced diabetes on hepatic ornithine decarboxylase activity in the ratJ H Levine, M G Buse, A B Leaming, et al.Diabetes Care|June 2, 2000
Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetesP Raskin, R A Guthrie, L Leiter, et al.The American Journal of the Medical Sciences|October 1, 1992
Relationship between insulin sensitivity and degree of obesity in mild hypertensionC Arauz-Pacheco, L C Ramirez, L Schnurr-Breen, et al.Journal of Diabetes and Its Complications|April 29, 1998
Effects of a large supper on glucose levels the following morning in patients with type 2 diabetesC Arauz-Pacheco, G Clements, S Cercone, et al.The New England Journal of Medicine|March 21, 1985
Potassium supplementation in hypertensive patients with diuretic-induced hypokalemiaN M Kaplan, A Carnegie, P Raskin, et al.Diabetes Care|July 15, 2000
Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetesP Raskin, L Jovanovic, S Berger, et al.Diabetes Care|November 25, 2000
A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetesP Raskin, L Klaff, R Bergenstal, et al.Pageof 16